TD2 - THE TRANSLATIONAL ONCOLOGY CRO
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Feb 2021)
What this means for you
This application is over — abandoned 22 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87509079
- Mark type
- Stylized text
- Filed
- 28 Jun 2017
- Published for opposition
- 21 Nov 2017
- Abandoned
- 22 Feb 2021
- Attorney of record
- Rodney J. Fuller
Goods and services
- Class 042 — Scientific and technological services: Consulting services for others in the field of design, planning, and implementation of project management for scientific research, clinical trials, and statistical analyses in the field of oncology; Scientific research, namely, conducting pre-clinical trials and supporting clinical trials for others; Providing scientific research information in the field of pre-clinical testing; Pharmaceutical drug development and related services, namely, pharmaceutical products development and pharmaceutical research services
Owner
- TRANSLATIONAL DRUG DEVELOPMENT, LLC, Scottsdale, AZ, US
- TRANSLATIONAL DRUG DEVELOPMENT, LLC, Scottsdale, AZ, US
Prosecution history
- 22 Feb 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Feb 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jul 2020 — SOU EXTENSION 5 GRANTED
- 16 Jul 2020 — SOU EXTENSION 5 FILED
- 16 Jul 2020 — SOU TEAS EXTENSION RECEIVED
- 17 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2020 — SOU EXTENSION 4 GRANTED
- 15 Jan 2020 — SOU EXTENSION 4 FILED
- 15 Jan 2020 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2019 — SOU EXTENSION 3 GRANTED
- 16 Jul 2019 — SOU EXTENSION 3 FILED
- 24 Sept 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Jul 2019 — NOTICE OF REVIVAL - E-MAILED